Fields, Taylor http://orcid.org/0000-0001-9506-4055
Schoser, Benedikt
Oertel, Wolfgang
Strupp, Michael
Article History
Received: 11 May 2021
Revised: 19 May 2021
Accepted: 21 May 2021
First Online: 30 May 2021
Declarations
:
: Taylor Fields is an officer and shareholder of IntraBio. Benedikt Schoser has received out of the scope of this report research grants from the European Union, Federal Ministry of Education and Research Germany; Sanofi-Genzyme, Amicus. Scientific advisory board fees, consulting fees, and speaker fees from Amicus, Alexion, Argenx, Audentes, Dyne, Lupin, Sanofi-Genzyme, UCB. Wolfgang Oertel has received grants from the ParkinsonFonds Deutschland, the Michael J Fox Foundation, and the Deutsche Forschungsgemeinschaft (DFG) outside the submitted work; he has received personal fees for educational and scientific presentations and/or for participating in advisory board meetings from Adamas, Desitin, MODAG, Roche and UCB outside the submitted work. Wolfgang Oertel is Hertie-Senior-Research Professor supported by the Charitable Hertie-Foundation, Frankfurt/Main, Germany. Michael Strupp is a shareholder to IntraBio, and consultant for Abbott, Actelion, AurisMedical, Heel, IntraBio and Sensorion out of the scope of this work; he has received speaker’s honoraria from Abbott, Actelion, Auris Medical, Biogen, Eisai, Grünenthal, GSK, Henning Pharma, Interacoustics, Johnson & Johnson, MSD, Otometrics, Pierre-Fabre, TEVA, UCB and Viatris outside of the work submitted. He is the distributor of M-glasses and positional vertigo App.
: Not applicable since description of a single case of individual off-label treatment. Written consent by the patient for compassionate-use of N-acetyl-DL-leucine.
: All authors had full access to the data in the case report and had final responsibility for the decision to submit for publication.